Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2161 AL 2175

Mitophagy in Neurodegenerative Diseases: Mechanisms of Action and the Advances of Drug Discovery

Yang P, Shuai W, Wang X, Hu X, Zhao M, Wang A, Wu Y, Ouyang L, Wang G.

J Med Chem. 2025 Feb 27;68(4):3970-3994. doi: 10.1021/acs.jmedchem.4c01779. Epub 2025 Feb 5.

The roles of functional bacterial amyloids in neurological physiology and pathophysiology: Pros and cons for neurodegeneration

Halimi H, Ahmadi B, Asri N, Rostami-Nejad M, Houri H.

Microb Pathog. 2025 Mar;200:107363. doi: 10.1016/j.micpath.2025.107363. Epub 2025 Feb 3.

Dual Uncommon Atrioventricular Connections in a Patient With Wolff-Parkinson-White Syndrome

Bisht DS, Kishor K.

J Cardiovasc Electrophysiol. 2025 Apr;36(4):900-904. doi: 10.1111/jce.16596. Epub 2025 Feb 5.

Effectiveness of Group Cognitive Behavioral Therapy on Quality of Life and Psychological Wellbeing of Patients With Parkinson Disease: A Randomized Controlled Trial

Narimisaei J, Naeim M, Nasiri Z, Imannezhad S, Mohammadi Y.

J Nerv Ment Dis. 2025 Mar 1;213(3):78-81. doi: 10.1097/NMD.0000000000001822. Epub 2025 Feb 6.

New Insights into the Association of Pesticide Exposure and Parkinson's Disease

Santos-Lobato BL.

Mov Disord. 2025 Mar;40(3):579-580. doi: 10.1002/mds.30135. Epub 2025 Feb 5.

Brain network and energy imbalance in Parkinson's disease: linking ATP reduction and α-synuclein pathology

Watanabe H, Shima S, Kawabata K, Mizutani Y, Ueda A, Ito M.

Front Mol Neurosci. 2025 Jan 22;17:1507033. doi: 10.3389/fnmol.2024.1507033. eCollection 2024.

Retrospective database analysis on the demographics and resource utilization of patients with Parkinson's disease in Quebec, Canada

Baribeau V, Mohammed S, Awan A, Parison D, Lachaine J.

Clin Park Relat Disord. 2025 Jan 12;12:100300. doi: 10.1016/j.prdoa.2025.100300. eCollection 2025.

The gut microbiome, immune modulation, and cognitive decline: insights on the gut-brain axis

Zhang R, Ding N, Feng X, Liao W.

Front Immunol. 2025 Jan 22;16:1529958. doi: 10.3389/fimmu.2025.1529958. eCollection 2025.

UK Biobank-A Unique Resource for Discovery and Translation Research on Genetics and Neurologic Disease

Taylor H, Lewins M, Foody MGB, Gray O, Bešević J, Conroy MC, Collins R, Lacey B, Allen N, Burkitt-Gray L.

Neurol Genet. 2025 Jan 17;11(1):e200226. doi: 10.1212/NXG.0000000000200226. eCollection 2025 Feb.

Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives

Yadav VK, Dhanasekaran S, Choudhary N, Nathiya D, Thakur V, Gupta R, Pramanik S, Kumar P, Gupta N, Patel A.

Front Med (Lausanne). 2025 Jan 22;12:1535682. doi: 10.3389/fmed.2025.1535682. eCollection 2025.

Development and validation of a sensitive sandwich ELISA against human PINK1

Baninameh Z, Watzlawik JO, Bustillos BA, Fiorino G, Yan T, Lewicki SL, Zhang H, Dickson DW, Siuda J, Wszolek ZK, Springer W, Fiesel FC.

Autophagy. 2025 May;21(5):1144-1159. doi: 10.1080/15548627.2025.2457915. Epub 2025 Feb 6.

Derivation of induced pluripotent stem cell TUSMi013-A from a 66-year-old Chinese Han Parkinson's disease patient carrying VPS13C and TBP mutations

Cui C, Chen J, Shen H, Zhang B.

Stem Cell Res. 2025 Mar;83:103631. doi: 10.1016/j.scr.2024.103631. Epub 2024 Dec 18.

Increased incidence of akinetic crises in Parkinson's disease patients treated with Levodopa-Carbidopa Intestinal Gel: A case series and review of the literature

Giannakis A, Tsamis K, Konitsiotis S.

Clin Neurol Neurosurg. 2025 Feb;249:108777. doi: 10.1016/j.clineuro.2025.108777. Epub 2025 Feb 4.

Beyond amyloid plaque, targeting α-synuclein in Alzheimer disease: The battle continues

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Ali AA, Abu-Alghayth MH.

Ageing Res Rev. 2025 Mar;105:102684. doi: 10.1016/j.arr.2025.102684. Epub 2025 Feb 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias